SLU-PP-332
250mcg × 100 capsules
❄Lyofilizovaný prášok (nerekonštituovaný)
Zľava za množstvo
| Množstvo | Zľava | Cena za jednotku |
|---|---|---|
| 5 - 10 | 10% | €48.60 |
| 11 - 20 | 15% | €45.90 |
| 21+ | 20% | €43.20 |
Prísne testovanie treťou stranou
Každá šarža našich výskumných chemikálií a peptidov prechádza nezávislým laboratórnym testovaním tretej strany na čistotu a identitu.
Celkom: €54.00
🔬Čo je SLU-PP-332
SLU-PP-332 is a selective Rev-ErbA agonist that modulates circadian rhythm-related metabolic pathways. It acts on nuclear receptors involved in lipid metabolism, energy expenditure, and mitochondrial function. Research suggests it may enhance exercise endurance and promote fat oxidation without affecting lean mass.
🏆Výhody
- Promotes fat oxidation through Rev-ErbA activation
- Enhances exercise endurance capacity
- Supports mitochondrial biogenesis and function
- Modulates circadian metabolic regulation
- May reduce fat mass without affecting muscle tissue
⚠️Možné vedľajšie účinky
- ▪Generally well-tolerated in research settings
- ▪Limited human clinical data available
- ▪Potential interactions with circadian-sensitive medications
- ▪Long-term safety profile under investigation
🎯Ideálne pre
- →Metabolic and fat oxidation research
- →Exercise endurance studies
- →Circadian rhythm and metabolism investigations
- →Body composition research
LABORATORY REAGENT – FOR RESEARCH PURPOSES ONLY
This product is not a drug or food and should be handled by qualified professionals in laboratory conditions. All product information is provided for educational purposes only.
Information:
- The product (substance) isn't a food or diet supplement and is not suitable for human consumption.
- Keep out of children's reach
- Keep container tightly closed.
- Store in a dry, cool and shaded place; protect from moisture.
- Store only in the original container.
- Avoid contact during pregnancy and breast feeding.
- Consult a doctor in the event of feeling unwell or having adverse effects related to the contact with the substance.